TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs72856718
log Bayes Factor = 16.3372
Chromosome 6   position 31,125,257  (GRCh37) Explore rs72856718 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
K90.0 Coeliac disease
0.000 0.000 1.000
E03.9 Hypothyroidism, unspecified
1.000 0.000 0.000
J45.9 Asthma, unspecified
0.000 0.268 0.732
K90 Intestinal malabsorption
0.000 0.279 0.721
R31 Unspecified haematuria
0.664 0.336 0.000
J45 Asthma
0.013 0.389 0.598
K90.9 Intestinal malabsorption, unspecified
0.000 0.425 0.575
J45.0 Predominantly allergic asthma
0.002 0.432 0.565
K90.8 Other intestinal malabsorption
0.000 0.483 0.517
K90.3 Pancreatic steatorrhoea
0.000 0.483 0.517
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.483 0.517
K90.1 Tropical sprue
0.000 0.483 0.517
K90-K93 Other diseases of the digestive system
0.000 0.488 0.512
E03 Other hypothyroidism
0.458 0.541 0.001
K92 Other diseases of digestive system
0.000 0.545 0.455
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.550 0.450
J45.8 Mixed asthma
0.009 0.562 0.429
J45.1 Nonallergic asthma
0.009 0.562 0.429
K92.1 Melaena
0.000 0.585 0.415
K92.2 Gastro-intestinal haemorrhage, unspecified
0.000 0.589 0.411
K91 Postprocedural disorders of digestive system, not elsewhere classified
0.000 0.595 0.405
K91.3 Postoperative intestinal obstruction
0.000 0.619 0.381
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.633 0.367
E03.5 Myxoedema coma
0.329 0.671 0.001
E03.4 Atrophy of thyroid (acquired)
0.329 0.671 0.001
E03.3 Postinfectious hypothyroidism
0.329 0.671 0.001
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.329 0.671 0.001
E03.1 Congenital hypothyroidism without goitre
0.329 0.671 0.001
E03.0 Congenital hypothyroidism with diffuse goitre
0.329 0.671 0.001
K91.0 Vomiting following gastro-intestinal surgery
0.000 0.679 0.321
K92.9 Disease of digestive system, unspecified
0.000 0.681 0.319
K92.8 Other specified diseases of digestive system
0.000 0.699 0.301
K91.9 Postprocedural disorder of digestive system, unspecified
0.000 0.709 0.291
K91.5 Postcholecystectomy syndrome
0.000 0.709 0.291
K91.2 Postsurgical malabsorption, not elsewhere classified
0.000 0.709 0.291
E03.8 Other specified hypothyroidism
0.267 0.732 0.001
J47 Bronchiectasis
0.263 0.736 0.001
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.000 0.736 0.263
K93.1 Megacolon in Chagas' disease
0.000 0.736 0.263
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.000 0.736 0.263
K91.1 Postgastric surgery syndromes
0.000 0.750 0.250
J40-J47 Chronic lower respiratory diseases
0.156 0.787 0.057
E10.9 Without complications
0.000 0.788 0.212
E78.0 Pure hypercholesterolaemia
0.209 0.791 0.000
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified
0.000 0.795 0.205
K91.4 Colostomy and enterostomy malfunction
0.000 0.801 0.199
E00-E07 Disorders of thyroid gland
0.195 0.804 0.001
E10 Insulin-dependent diabetes mellitus
0.000 0.806 0.194
E10.3 With ophthalmic complications
0.000 0.830 0.170
E06 Thyroiditis
0.168 0.831 0.001
J42 Unspecified chronic bronchitis
0.147 0.837 0.016
J40 Bronchitis, not specified as acute or chronic
0.153 0.839 0.008
K92.0 Haematemesis
0.000 0.845 0.155
E10.4 With neurological complications
0.000 0.846 0.154
J41 Simple and mucopurulent chronic bronchitis
0.112 0.847 0.041
E10.1 With ketoacidosis
0.000 0.848 0.151
E07 Other disorders of thyroid
0.146 0.853 0.001
E10-E14 Diabetes mellitus
0.003 0.855 0.142
E06.3 Autoimmune thyroiditis
0.141 0.859 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.140 0.859 0.001
E00 Congenital iodine-deficiency syndrome
0.140 0.859 0.001
E02 Subclinical iodine-deficiency hypothyroidism
0.140 0.859 0.001
E10.8 With unspecified complications
0.000 0.861 0.139
E10.7 With multiple complications
0.000 0.861 0.139
E10.6 With other specified complications
0.000 0.861 0.139
E10.0 With coma
0.000 0.861 0.139
E10.2 With renal complications
0.000 0.861 0.138
E10.5 With peripheral circulatory complications
0.000 0.863 0.137
E06.9 Thyroiditis, unspecified
0.135 0.865 0.000
E14 Unspecified diabetes mellitus
0.001 0.866 0.133
J43 Emphysema
0.071 0.875 0.054
E06.5 Other chronic thyroiditis
0.121 0.879 0.001
E06.4 Drug-induced thyroiditis
0.121 0.879 0.001
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.121 0.879 0.001
E06.1 Subacute thyroiditis
0.121 0.879 0.001
E06.0 Acute thyroiditis
0.121 0.879 0.001
E14.9 Without complications
0.000 0.882 0.118
E14.3 With ophthalmic complications
0.000 0.883 0.116
E13 Other specified diabetes mellitus
0.002 0.885 0.113
E07.9 Disorder of thyroid, unspecified
0.111 0.888 0.000
J41.8 Mixed simple and mucopurulent chronic bronchitis
0.081 0.890 0.029
J41.1 Mucopurulent chronic bronchitis
0.081 0.890 0.029
J41.0 Simple chronic bronchitis
0.081 0.890 0.029
J46 Status asthmaticus
0.059 0.890 0.050
E07.8 Other specified disorders of thyroid
0.105 0.894 0.001
E07.1 Dyshormogenetic goitre
0.105 0.894 0.001
E07.0 Hypersecretion of calcitonin
0.105 0.894 0.001
E12 Malnutrition-related diabetes mellitus
0.003 0.896 0.102
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.100 0.899 0.001
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.100 0.899 0.001
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.100 0.899 0.001
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.100 0.899 0.001
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.100 0.899 0.001
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.100 0.899 0.001
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.100 0.899 0.001
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.100 0.899 0.001
E04 Other non-toxic goitre
0.099 0.901 0.001
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.097 0.902 0.000
E14.8 With unspecified complications
0.001 0.904 0.095
E14.7 With multiple complications
0.001 0.904 0.095
E14.6 With other specified complications
0.001 0.904 0.095
E14.5 With peripheral circulatory complications
0.001 0.904 0.095
E14.4 With neurological complications
0.001 0.904 0.095
E14.2 Withrenal complications
0.001 0.904 0.095
E14.1 With ketoacidosis
0.001 0.904 0.095
E14.0 With coma
0.001 0.904 0.095
E13.9 Without complications
0.001 0.907 0.092
J43.8 Other emphysema
0.051 0.910 0.039
J43.1 Panlobular emphysema
0.051 0.910 0.039
J43.0 MacLeod's syndrome
0.051 0.910 0.039
J43.2 Centrilobular emphysema
0.053 0.912 0.036
E13.8 With unspecified complications
0.002 0.917 0.081
E13.7 With multiple complications
0.002 0.917 0.081
E13.6 With other specified complications
0.002 0.917 0.081
E13.5 With peripheral circulatory complications
0.002 0.917 0.081
E13.4 With neurological complications
0.002 0.917 0.081
E13.3 With ophthalmic complications
0.002 0.917 0.081
E13.2 With renal complications
0.002 0.917 0.081
E13.1 With ketoacidosis
0.002 0.917 0.081
E13.0 With coma
0.002 0.917 0.081
E05 Thyrotoxicosis [hyperthyroidism]
0.080 0.919 0.001
Chapter IV Endocrine, nutritional and metabolic diseases
0.071 0.920 0.009
E78.4 Other hyperlipidaemia
0.077 0.923 0.000
E12.9 Without complications
0.002 0.925 0.073
E12.8 With unspecified complications
0.002 0.925 0.073
E12.7 With multiple complications
0.002 0.925 0.073
E12.6 With other specified complications
0.002 0.925 0.073
E12.5 With peripheral circulatory complications
0.002 0.925 0.073
E12.4 With neurological complications
0.002 0.925 0.073
E12.3 With ophthalmic complications
0.002 0.925 0.073
E12.2 With renal complications
0.002 0.925 0.073
E12.1 With ketoacidosis
0.002 0.925 0.073
E12.0 With coma
0.002 0.925 0.073
E78.9 Disorder of lipoprotein metabolism, unspecified
0.073 0.927 0.000
E04.8 Other specified non-toxic goitre
0.071 0.929 0.001
E04.0 Non-toxic diffuse goitre
0.070 0.929 0.000
E70-E90 Metabolic disorders
0.069 0.929 0.002
E78.6 Lipoprotein deficiency
0.070 0.930 0.000
E78.3 Hyperchylomicronaemia
0.070 0.930 0.000
E78.1 Pure hyperglyceridaemia
0.070 0.930 0.000
E11 Non-insulin-dependent diabetes mellitus
0.000 0.931 0.068
E78.8 Other disorders of lipoprotein metabolism
0.067 0.932 0.000
E04.9 Non-toxic goitre, unspecified
0.067 0.933 0.000
I21.9 Acute myocardial infarction, unspecified
0.067 0.933 0.000
E11.4 With neurological complications
0.000 0.939 0.061
E78.2 Mixed hyperlipidaemia
0.060 0.939 0.000
E40-E46 Malnutrition
0.055 0.939 0.005
E11.1 With ketoacidosis
0.000 0.940 0.059
E04.1 Non-toxic single thyroid nodule
0.059 0.940 0.000
E65-E68 Obesity and other hyperalimentation
0.056 0.941 0.003
E05.8 Other thyrotoxicosis
0.057 0.942 0.001
E05.5 Thyroid crisis or storm
0.057 0.942 0.001
E05.4 Thyrotoxicosis factitia
0.057 0.942 0.001
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.057 0.942 0.001
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.057 0.942 0.001
J43.9 Emphysema, unspecified
0.005 0.942 0.053
E04.2 Non-toxic multinodular goitre
0.057 0.943 0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.057 0.943 0.001
E11.5 With peripheral circulatory complications
0.000 0.945 0.055
E83 Disorders of mineral metabolism
0.052 0.947 0.001
E80 Disorders of porphyrin and bilirubin metabolism
0.051 0.948 0.001
E74 Other disorders of carbohydrate metabolism
0.051 0.948 0.001
E84 Cystic fibrosis
0.050 0.949 0.001
E79 Disorders of purine and pyrimidine metabolism
0.050 0.949 0.001
E77 Disorders of glycoprotein metabolism
0.050 0.949 0.001
E76 Disorders of glycosaminoglycan metabolism
0.050 0.949 0.001
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.050 0.949 0.001
E72 Other disorders of amino-acid metabolism
0.050 0.949 0.001
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.050 0.949 0.001
E70 Disorders of aromatic amino-acid metabolism
0.050 0.949 0.001
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.050 0.949 0.001
E11.7 With multiple complications
0.000 0.951 0.049
E85 Amyloidosis
0.047 0.951 0.001
E65 Localised adiposity
0.047 0.951 0.002
E11.8 With unspecified complications
0.000 0.951 0.048
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.042 0.952 0.007
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.047 0.952 0.001
E50-E64 Other nutritional deficiencies
0.041 0.952 0.006
I21 Acute myocardial infarction
0.047 0.953 0.000
E83.4 Disorders of magnesium metabolism
0.047 0.953 0.000
E46 Unspecified protein-energy malnutrition
0.044 0.953 0.003
D50.8 Other iron deficiency anaemias
0.000 0.954 0.046
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency
0.000 0.954 0.046
E73 Lactose intolerance
0.043 0.955 0.002
E44 Protein-energy malnutrition of moderate and mild degree
0.040 0.956 0.004
E45 Retarded development following protein-energy malnutrition
0.040 0.956 0.004
E43 Unspecified severe protein-energy malnutrition
0.040 0.956 0.004
E42 Marasmic kwashiorkor
0.040 0.956 0.004
E41 Nutritional marasmus
0.040 0.956 0.004
E40 Kwashiorkor
0.040 0.956 0.004
E05.9 Thyrotoxicosis, unspecified
0.043 0.957 0.000
D51 Vitamin B12 deficiency anaemia
0.000 0.957 0.043
E67 Other hyperalimentation
0.040 0.957 0.003
E68 Sequelae of hyperalimentation
0.040 0.957 0.003
E11.6 With other specified complications
0.000 0.958 0.042
E11.2 With renal complications
0.000 0.958 0.041
E83.3 Disorders of phosphorus metabolism
0.041 0.959 0.001
I20-I25 Ischaemic heart diseases
0.041 0.959 0.000
I21.0 Acute transmural myocardial infarction of anterior wall
0.040 0.960 0.000
I20 Angina pectoris
0.040 0.960 0.000
T91 Sequelae of injuries of neck and trunk
0.040 0.960 0.000
E11.0 With coma
0.001 0.960 0.039
D50 Iron deficiency anaemia
0.000 0.961 0.039
I20.9 Angina pectoris, unspecified
0.039 0.961 0.000
D50-D53 Nutritional anaemias
0.000 0.961 0.039
E80.4 Gilbert's syndrome
0.038 0.961 0.001
E74.3 Other disorders of intestinal carbohydrate absorption
0.037 0.962 0.001
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes
0.038 0.962 0.000
E83.9 Disorder of mineral metabolism, unspecified
0.037 0.962 0.001
E83.8 Other disorders of mineral metabolism
0.037 0.962 0.001
E83.2 Disorders of zinc metabolism
0.037 0.962 0.001
E83.0 Disorders of copper metabolism
0.037 0.962 0.001
E88 Other metabolic disorders
0.036 0.962 0.002
E80.7 Disorder of bilirubin metabolism, unspecified
0.037 0.962 0.001
E80.6 Other disorders of bilirubin metabolism
0.037 0.962 0.001
E80.5 Crigler-Najjar syndrome
0.037 0.962 0.001
E80.3 Defects of catalase and peroxydase
0.037 0.962 0.001
E80.2 Other porphyria
0.037 0.962 0.001
E80.1 Porphyria cutanea tarda
0.037 0.962 0.001
E80.0 Hereditary erythropoietic porphyria
0.037 0.962 0.001
E74.9 Disorder of carbohydrate metabolism, unspecified
0.036 0.962 0.001
E74.8 Other specified disorders of carbohydrate metabolism
0.036 0.962 0.001
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.036 0.962 0.001
E74.2 Disorders of galactose metabolism
0.036 0.962 0.001
E74.1 Disorders of fructose metabolism
0.036 0.962 0.001
E74.0 Glycogen storage disease
0.036 0.962 0.001
E66 Obesity
0.036 0.963 0.001
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.037 0.963 0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.036 0.963 0.001
E70.8 Other disorders of aromatic amino-acid metabolism
0.036 0.963 0.001
E70.3 Albinism
0.036 0.963 0.001
E70.2 Disorders of tyrosine metabolism
0.036 0.963 0.001
E70.1 Other hyperphenylalaninaemias
0.036 0.963 0.001
E70.0 Classical phenylketonuria
0.036 0.963 0.001
E71.3 Disorders of fatty-acid metabolism
0.036 0.963 0.001
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.036 0.963 0.001
E71.1 Other disorders of branched-chain amino-acid metabolism
0.036 0.963 0.001
E71.0 Maple-syrup-urine disease
0.036 0.963 0.001
E72.9 Disorder of amino-acid metabolism, unspecified
0.036 0.963 0.001
E72.8 Other specified disorders of amino-acid metabolism
0.036 0.963 0.001
E72.5 Disorders of glycine metabolism
0.036 0.963 0.001
E72.4 Disorders of ornithine metabolism
0.036 0.963 0.001
E72.3 Disorders of lysine and hydroxylysine metabolism
0.036 0.963 0.001
E72.2 Disorders of urea cycle metabolism
0.036 0.963 0.001
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.036 0.963 0.001
E72.0 Disorders of amino-acid transport
0.036 0.963 0.001
E75.6 Lipid storage disorder, unspecified
0.036 0.963 0.001
E75.5 Other lipid storage disorders
0.036 0.963 0.001
E75.4 Neuronal ceroid lipofuscinosis
0.036 0.963 0.001
E75.3 Sphingolipidosis, unspecified
0.036 0.963 0.001
E75.2 Other sphingolipidosis
0.036 0.963 0.001
E75.1 Other gangliosidosis
0.036 0.963 0.001
E75.0 GM2 gangliosidosis
0.036 0.963 0.001
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.036 0.963 0.001
E76.8 Other disorders of glucosaminoglycan metabolism
0.036 0.963 0.001
E76.3 Mucopolysaccharidosis, unspecified
0.036 0.963 0.001
E76.2 Other mucopolysaccharidoses
0.036 0.963 0.001
E76.1 Mucopolysaccharidosis, type II
0.036 0.963 0.001
E76.0 Mucopolysaccharidosis, type I
0.036 0.963 0.001
E77.9 Disorder of glycoprotein metabolism, unspecified
0.036 0.963 0.001
E77.8 Other disorders of glycoprotein metabolism
0.036 0.963 0.001
E77.1 Defects in glycoprotein degradation
0.036 0.963 0.001
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.036 0.963 0.001
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.036 0.963 0.001
E79.8 Other disorders of purine and pyrimidine metabolism
0.036 0.963 0.001
E79.1 Lesch-Nyhan syndrome
0.036 0.963 0.001
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.036 0.963 0.001
E84.9 Cystic fibrosis, unspecified
0.036 0.963 0.001
E84.8 Cystic fibrosis with other manifestations
0.036 0.963 0.001
E84.1 Cystic fibrosis with intestinal manifestations
0.036 0.963 0.001
E84.0 Cystic fibrosis with pulmonary manifestations
0.036 0.963 0.001
E61 Deficiency of other nutrient elements
0.033 0.963 0.003
E83.5 Disorders of calcium metabolism
0.036 0.963 0.000
I20.0 Unstable angina
0.037 0.963 0.000
E89.2 Postprocedural hypoparathyroidism
0.036 0.963 0.001
T36-T50 Poisoning by drugs, medicaments and biological substances
0.036 0.964 0.000
T91.3 Sequelae of injury of spinal cord
0.036 0.964 0.000
T42.4 Benzodiazepines
0.035 0.965 0.000
E85.9 Amyloidosis, unspecified
0.034 0.965 0.001
E85.8 Other amyloidosis
0.034 0.965 0.001
E85.3 Secondary systemic amyloidosis
0.034 0.965 0.001
E85.2 Heredofamilial amyloidosis, unspecified
0.034 0.965 0.001
E85.1 Neuropathic heredofamilial amyloidosis
0.034 0.965 0.001
E85.0 Nonneuropathic heredofamilial amyloidosis
0.034 0.965 0.001
E15 Nondiabetic hypoglycaemic coma
0.030 0.965 0.005
I22 Subsequent myocardial infarction
0.035 0.965 0.000
D51.9 Vitamin B12 deficiency anaemia, unspecified
0.000 0.965 0.035
E89.0 Postprocedural hypothyroidism
0.034 0.965 0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.034 0.965 0.001
E89.8 Other postprocedural endocrine and metabolic disorders
0.034 0.965 0.001
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.034 0.965 0.001
E89.5 Postprocedural testicular hypofunction
0.034 0.965 0.001
E89.4 Postprocedural ovarian failure
0.034 0.965 0.001
E89.1 Postprocedural hypoinsulinaemia
0.034 0.965 0.001
T91.1 Sequelae of fracture of spine
0.035 0.965 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.030 0.966 0.005
E63 Other nutritional deficiencies
0.030 0.966 0.005
E56 Other vitamin deficiencies
0.030 0.966 0.005
E51 Thiamine deficiency
0.030 0.966 0.005
E50 Vitamin A deficiency
0.030 0.966 0.005
E60 Dietary zinc deficiency
0.030 0.966 0.005
E59 Dietary selenium deficiency
0.030 0.966 0.005
E58 Dietary calcium deficiency
0.030 0.966 0.005
E54 Ascorbic acid deficiency
0.030 0.966 0.005
E52 Niacin deficiency [pellagra]
0.030 0.966 0.005
I21.X Presumed acute myicardial infaction (unconfirmed)
0.034 0.966 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.034 0.966 0.000
T91.8 Sequelae of other specified injuries of neck and trunk
0.034 0.966 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.033 0.967 0.000
E85.4 Organ-limited amyloidosis
0.032 0.967 0.001
T90 Sequelae of injuries of head
0.033 0.967 0.000
T91.9 Sequelae of unspecified injury of neck and trunk
0.033 0.967 0.000
T93 Sequelae of injuries of lower limb
0.033 0.967 0.000
E66.8 Other obesity
0.033 0.967 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.032 0.967 0.001
E73.8 Other lactose intolerance
0.031 0.967 0.001
E73.1 Secondary lactase deficiency
0.031 0.967 0.001
E73.0 Congenital lactase deficiency
0.031 0.967 0.001
I21.1 Acute transmural myocardial infarction of inferior wall
0.032 0.968 0.000
E11.3 With ophthalmic complications
0.000 0.968 0.032
I21.2 Acute transmural myocardial infarction of other sites
0.032 0.968 0.000
I21.3 Acute transmural myocardial infarction of unspecified site
0.032 0.968 0.000
T91.2 Sequelae of other fracture of thorax and pelvis
0.032 0.968 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.032 0.968 0.000
E44.1 Mild protein-energy malnutrition
0.029 0.968 0.003
E44.0 Moderate protein-energy malnutrition
0.029 0.968 0.003
I22.1 Subsequent myocardial infarction of inferior wall
0.031 0.969 0.000
I25.1 Atherosclerotic heart disease
0.031 0.969 0.000
T94 Sequelae of injuries involving multiple and unspecified body regions
0.031 0.969 0.000
D51.8 Other vitamin B12 deficiency anaemias
0.000 0.969 0.031
D51.3 Other dietary vitamin B12 deficiency anaemia
0.000 0.969 0.031
D51.2 Transcobalamin II deficiency
0.000 0.969 0.031
D51.1 Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria
0.000 0.969 0.031
E67.8 Other specified hyperalimentation
0.029 0.969 0.002
E67.3 Hypervitaminosis D
0.029 0.969 0.002
E67.2 Megavitamin-B6 syndrome
0.029 0.969 0.002
E67.1 Hypercarotenaemia
0.029 0.969 0.002
E67.0 Hypervitaminosis A
0.029 0.969 0.002
Chapter XIX Injury, poisoning and certain other consequences of external causes
0.031 0.969 0.000
I23 Certain current complications following acute myocardial infarction
0.030 0.970 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.030 0.970 0.000
I25 Chronic ischaemic heart disease
0.030 0.970 0.000
T91.5 Sequelae of injury of intra-abdominal and pelvic organs
0.029 0.971 0.000
T91.4 Sequelae of injury of intrathoracic organs
0.029 0.971 0.000
T91.0 Sequelae of superficial injury and open wound of neck and trunk
0.029 0.971 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.029 0.971 0.000
E61.2 Magnesium deficiency
0.027 0.971 0.002
E55 Vitamin D deficiency
0.024 0.971 0.005
E89.3 Postprocedural hypopituitarism
0.028 0.971 0.001
D50.1 Sideropenic dysphagia
0.000 0.971 0.028
I20.1 Angina pectoris with documented spasm
0.028 0.971 0.000
S40-S49 Injuries to the shoulder and upper arm
0.028 0.972 0.000
D53 Other nutritional anaemias
0.000 0.972 0.028
J44 Other chronic obstructive pulmonary disease
0.022 0.972 0.006
E20-E35 Disorders of other endocrine glands
0.020 0.972 0.008
T42.1 Iminostilbenes
0.028 0.972 0.000
T95 Sequelae of burns, corrosions and frostbite
0.028 0.972 0.000
T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source
0.028 0.972 0.000
T96 Sequelae of poisoning by drugs, medicaments and biological substances
0.028 0.972 0.000
T93.3 Sequelae of dislocation, sprain and strain of lower limb
0.028 0.972 0.000
E88.9 Metabolic disorder, unspecified
0.026 0.972 0.002
E88.8 Other specified metabolic disorders
0.026 0.972 0.002
E88.3 Tumour lysis syndrome
0.026 0.972 0.002
E88.2 Lipomatosis, not elsewhere classified
0.026 0.972 0.002
E88.1 Lipodystrophy, not elsewhere classified
0.026 0.972 0.002
E61.1 Iron deficiency
0.026 0.973 0.002
T93.9 Sequelae of unspecified injury of lower limb
0.027 0.973 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.027 0.973 0.000
E66.2 Extreme obesity with alveolar hypoventilation
0.026 0.973 0.001
E66.1 Drug-induced obesity
0.026 0.973 0.001
E66.0 Obesity due to excess calories
0.026 0.973 0.001
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.027 0.973 0.000
T79-T79 Certain early complications of trauma
0.027 0.973 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.027 0.973 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.027 0.973 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.027 0.973 0.000
T42.3 Barbiturates
0.027 0.973 0.000
T42.2 Succinimides and oxazolidinediones
0.027 0.973 0.000
T42.0 Hydantoin derivatives
0.027 0.973 0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source
0.027 0.973 0.000
I22.9 Subsequent myocardial infarction of unspecified site
0.027 0.973 0.000
E61.9 Deficiency of nutrient element, unspecified
0.024 0.973 0.003
E61.8 Deficiency of other specified nutrient elements
0.024 0.973 0.003
E61.7 Deficiency of multiple nutrient elements
0.024 0.973 0.003
E61.6 Vanadium deficiency
0.024 0.973 0.003
E61.5 Molybdenum deficiency
0.024 0.973 0.003
E61.4 Chromium deficiency
0.024 0.973 0.003
E61.3 Manganese deficiency
0.024 0.973 0.003
E61.0 Copper deficiency
0.024 0.973 0.003
T90.5 Sequelae of intracranial injury
0.027 0.973 0.000
E73.9 Lactose intolerance, unspecified
0.025 0.973 0.002
T92 Sequelae of injuries of upper limb
0.026 0.974 0.000
T98 Sequelae of other and unspecified effects of external causes
0.026 0.974 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.026 0.974 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.026 0.974 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.026 0.974 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.026 0.974 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.026 0.974 0.000
T36 Poisoning by systemic antibiotics
0.026 0.974 0.000
E53 Deficiency of other B group vitamins
0.021 0.974 0.005
T90.4 Sequelae of injury of eye and orbit
0.026 0.974 0.000
E16 Other disorders of pancreatic internal secretion
0.020 0.974 0.006
T94.1 Sequelae of injuries, not specified by body region
0.026 0.974 0.000
T90.8 Sequelae of other specified injuries of head
0.025 0.974 0.000
D52 Folate deficiency anaemia
0.000 0.975 0.025
T43.0 Tricyclic and tetracyclic antidepressants
0.025 0.975 0.000
T93.8 Sequelae of other specified injuries of lower limb
0.025 0.975 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.025 0.975 0.000
D50.9 Iron deficiency anaemia, unspecified
0.000 0.975 0.025
E50.9 Vitamin A deficiency, unspecified
0.022 0.975 0.003
E50.8 Other manifestations of vitamin A deficiency
0.022 0.975 0.003
E50.7 Other ocular manifestations of vitamin A deficiency
0.022 0.975 0.003
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.022 0.975 0.003
E50.5 Vitamin A deficiency with night blindness
0.022 0.975 0.003
E50.4 Vitamin A deficiency with keratomalacia
0.022 0.975 0.003
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.022 0.975 0.003
E50.2 Vitamin A deficiency with corneal xerosis
0.022 0.975 0.003
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.022 0.975 0.003
E50.0 Vitamin A deficiency with conjunctival xerosis
0.022 0.975 0.003
E51.9 Thiamine deficiency, unspecified
0.022 0.975 0.003
E51.8 Other manifestations of thiamine deficiency
0.022 0.975 0.003
E51.2 Wernicke's encephalopathy
0.022 0.975 0.003
E51.1 Beriberi
0.022 0.975 0.003
E56.9 Vitamin deficiency, unspecified
0.022 0.975 0.003
E56.8 Deficiency of other vitamins
0.022 0.975 0.003
E56.1 Deficiency of vitamin K
0.022 0.975 0.003
E56.0 Deficiency of vitamin E
0.022 0.975 0.003
E63.9 Nutritional deficiency, unspecified
0.022 0.975 0.003
E63.8 Other specified nutritional deficiencies
0.022 0.975 0.003
E63.1 Imbalance of constituents of food intake
0.022 0.975 0.003
E63.0 Essential fatty acid [EFA] deficiency
0.022 0.975 0.003
E64.9 Sequelae of unspecified nutritional deficiency
0.022 0.975 0.003
E64.8 Sequelae of other nutritional deficiencies
0.022 0.975 0.003
E64.3 Sequelae of rickets
0.022 0.975 0.003
E64.2 Sequelae of vitamin C deficiency
0.022 0.975 0.003
E64.1 Sequelae of vitamin A deficiency
0.022 0.975 0.003
E64.0 Sequelae of protein-energy malnutrition
0.022 0.975 0.003
T90.9 Sequelae of unspecified injury of head
0.025 0.975 0.000
I22.0 Subsequent myocardial infarction of anterior wall
0.025 0.975 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.025 0.975 0.000
T43.2 Other and unspecified antidepressants
0.025 0.975 0.000
T79 Certain early complications of trauma, not elsewhere classified
0.024 0.976 0.000
T08-T14 Injuries to unspecified part of trunk, limb or body region
0.024 0.976 0.000
T90.2 Sequelae of fracture of skull and facial bones
0.024 0.976 0.000
S10-S19 Injuries to the neck
0.024 0.976 0.000
T50.8 Diagnostic agents
0.024 0.976 0.000
T50.7 Analeptics and opioid receptor antagonists
0.024 0.976 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.024 0.976 0.000
T50.5 Appetite depressants
0.024 0.976 0.000
T50.4 Drugs affecting uric acid metabolism
0.024 0.976 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.024 0.976 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.024 0.976 0.000
T50.1 Loop [high-ceiling] diuretics
0.024 0.976 0.000
T50.0 Mineralocorticoids and their antagonists
0.024 0.976 0.000
I25.3 Aneurysm of heart
0.024 0.976 0.000
T90.3 Sequelae of injury of cranial nerves
0.024 0.976 0.000
T90.1 Sequelae of open wound of head
0.024 0.976 0.000
T90.0 Sequelae of superficial injury of head
0.024 0.976 0.000
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb
0.024 0.976 0.000
T93.5 Sequelae of injury of muscle and tendon of lower limb
0.024 0.976 0.000
T93.4 Sequelae of injury of nerve of lower limb
0.024 0.976 0.000
T93.1 Sequelae of fracture of femur
0.024 0.976 0.000
T93.0 Sequelae of open wound of lower limb
0.024 0.976 0.000
I22.8 Subsequent myocardial infarction of other sites
0.024 0.976 0.000
T20-T25 Burns and corrosions of external body surface, specified by site
0.024 0.976 0.000
T45.0 Antiallergic and antiemetic drugs
0.023 0.976 0.000
S40 Superficial injury of shoulder and upper arm
0.023 0.976 0.000
S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle
0.023 0.977 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.023 0.977 0.000
S50-S59 Injuries to the elbow and forearm
0.023 0.977 0.000
I23.8 Other current complications following acute myocardial infarction
0.023 0.977 0.000
T59 Toxic effect of other gases, fumes and vapours
0.023 0.977 0.000
T93.2 Sequelae of other fractures of lower limb
0.023 0.977 0.000
S42 Fracture of shoulder and upper arm
0.022 0.977 0.000
T94.0 Sequelae of injuries involving multiple body regions
0.022 0.978 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.022 0.978 0.000
I20.8 Other forms of angina pectoris
0.022 0.978 0.000
E86 Volume depletion
0.022 0.978 0.000
T33-T35 Frostbite
0.022 0.978 0.000
T26-T28 Burns and corrosions confined to eye and internal organs
0.022 0.978 0.000
T00-T07 Injuries involving multiple body regions
0.022 0.978 0.000
S46 Injury of muscle and tendon at shoulder and upper arm level
0.022 0.978 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.022 0.978 0.000
T79.7 Traumatic subcutaneous emphysema
0.022 0.978 0.000
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction
0.022 0.978 0.000
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction
0.022 0.978 0.000
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction
0.022 0.978 0.000
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction
0.022 0.978 0.000
I23.2 Ventricular septal defect as current complication following acute myocardial infarction
0.022 0.978 0.000
I23.1 Atrial septal defect as current complication following acute myocardial infarction
0.022 0.978 0.000
I23.0 Haemopericardium as current complication following acute myocardial infarction
0.022 0.978 0.000
S41 Open wound of shoulder and upper arm
0.022 0.978 0.000
T38.1 Thyroid hormones and substitutes
0.022 0.978 0.000
T66-T78 Other and unspecified effects of external causes
0.022 0.978 0.000
T29-T32 Burns and corrosions of multiple and unspecified body regions
0.022 0.978 0.000
S40.0 Contusion of shoulder and upper arm
0.022 0.978 0.000
T43.9 Psychotropic drug, unspecified
0.022 0.978 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.022 0.978 0.000
T43.6 Psychostimulants with abuse potential
0.022 0.978 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.022 0.978 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.